Schilders G, Egberts WV, Raijmakers R, Pruijn GJ (July 2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome". Arthritis and Rheumatism. 56 (7): 2449–2454. doi:10.1002/art.22710. hdl:2066/35047. PMID17599775.
Schilders G, Egberts WV, Raijmakers R, Pruijn GJ (July 2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome". Arthritis and Rheumatism. 56 (7): 2449–2454. doi:10.1002/art.22710. hdl:2066/35047. PMID17599775.
Erdemir T, Bilican B, Oncel D, Goding CR, Yavuzer U (January 2002). "DNA damage-dependent interaction of the nuclear matrix protein C1D with Translin-associated factor X (TRAX)". Journal of Cell Science. 115 (Pt 1): 207–216. doi:10.1242/jcs.115.1.207. hdl:11693/24740. PMID11801738.
Erdemir T, Bilican B, Oncel D, Goding CR, Yavuzer U (January 2002). "DNA damage-dependent interaction of the nuclear matrix protein C1D with Translin-associated factor X (TRAX)". Journal of Cell Science. 115 (Pt 1): 207–216. doi:10.1242/jcs.115.1.207. hdl:11693/24740. PMID11801738.
Schilders G, Egberts WV, Raijmakers R, Pruijn GJ (July 2007). "C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome". Arthritis and Rheumatism. 56 (7): 2449–2454. doi:10.1002/art.22710. hdl:2066/35047. PMID17599775.